|
cytokines |
5 |
|
immunoglobulins |
5 |
|
infectious disease |
5 |
|
macrophages |
5 |
|
mdscs |
5 |
|
pulmonology |
5 |
|
antigen spreading |
4 |
|
cd8+t cells |
4 |
|
cd8-positive t-lymphocytes - immunology - virology |
4 |
|
ctls |
4 |
|
dna vaccine |
4 |
|
entry inhibitor |
4 |
|
glycomics |
4 |
|
glycoprotein |
4 |
|
glycosylation |
4 |
|
highly active antiretroviral therapy |
4 |
|
hiv core protein p24 - immunology |
4 |
|
hiv infections - prevention and control |
4 |
|
hiv-1 - immunology |
4 |
|
human immunodeficiency virus |
4 |
|
human programmed cell death protein 1 |
4 |
|
immune response |
4 |
|
immunity |
4 |
|
immunology and microbiology section |
4 |
|
mass spectrometry |
4 |
|
memory cd8 t cell response |
4 |
|
mesothelioma |
4 |
|
modified vaccinia tiantan |
4 |
|
persistent virus infection |
4 |
|
programmed cell death 1 receptor - immunology |
4 |
|
sanguisorba officinalis |
4 |
|
t cell exhaustion |
4 |
|
traditional chinese medicine |
4 |
|
vaccination |
4 |
|
vaccine |
4 |
|
virotherapy |
4 |
|
adeno-associated virus |
3 |
|
bcg |
3 |
|
beropt |
3 |
|
ctla-4 |
3 |
|
cytotoxic t lymphocytes |
3 |
|
immune checkpoint blockade |
3 |
|
immunotherapy |
3 |
|
mycobacterium tuberculosis |
3 |
|
pd-1 |
3 |
|
pd1 |
3 |
|
pd1-based vaccination |
3 |
|
soluble pd1-based vaccination |
3 |
|
t cell immunity |
3 |
|
tuberculosis |
3 |
|
twist1 antigen |
3 |
|
allergology and immunology |
2 |
|
antiviral |
2 |
|
antiviral activity |
2 |
|
hiv-1 capsid assembly |
2 |
|
hiv-1 tat-tar |
2 |
|
inhibitor |
2 |
|
medical sciences |
2 |
|
mesothelioma - immunotherapy |
2 |
|
molecular modeling |
2 |
|
n-acylhydrazone derivatives |
2 |
|
quinoline derivatives |
2 |
|
synthesis |
2 |
|
acylhydrazone derivatives |
1 |
|
acylhydrazones |
1 |
|
assembly |
1 |
|
capsid |
1 |
|
capsid assembly |
1 |
|
cyclophilin a |
1 |
|
disassembly |
1 |
|
dual inhibitor |
1 |
|
hiv-1 |
1 |
|
hiv-1 capsid |
1 |
|
human cyclophilin a |
1 |
|
inhibitory activity evaluation |
1 |
|
sar |
1 |
|
thiourea derivatives |
1 |
